PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer

NCT03081715 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hangzhou Cancer Hospital

Collaborators